Secondary chondrosarcoma of the iliac bone in a young woman – a rare case report and review of the literature

Authors

  • Therese David Department of Histopathology, Apollo Hospitals, Chennai, India https://orcid.org/0009-0001-7034-6256
  • Swetha Lakshmi Narla Department of Histopathology, Apollo Hospitals, Chennai, India https://orcid.org/0000-0001-8490-6392
  • Annapurneswari Subramanyan Department of Histopathology, Apollo Hospitals, Chennai, India
  • Kathiresan N. Department of Surgical Oncology, Apollo Hospitals, Chennai, India

DOI:

https://doi.org/10.15584/ejcem.2025.2.25

Keywords:

chondrosarcoma, iliac bone, malignant transformation, osteochondroma

Abstract

Introduction and aim. Chondrosarcomas are malignant cartilage-forming tumors, with secondary cases rarely arising from osteochondromas. This report presents a case of secondary chondrosarcoma developing from an undiagnosed pelvic osteo chondroma in a young female, emphasizing the importance of early detection and timely intervention.

Description of the case. A 28-year-old woman with hip and back pain underwent magnetic resonance imaging, revealing a le sion in the left iliacus muscle with sacroiliac extension. Biopsy confirmed a chondroid neoplasm, and positron emission topog raphy-computed tomography showed minimal metabolic activity. Due to the extensive soft tissue component and recurrence risk, wide local excision was performed. Histology confirmed well-differentiated secondary chondrosarcoma, WHO grade 1 arising from an undiagnosed pre-existing osteochondroma.

Conclusion. The described case highlights the critical role of radiological and histopathological evaluation, timely surgical in tervention, and multidisciplinary management for optimal patient outcomes.

Downloads

Download data is not yet available.

References

Thorkildsen J, Taksdal I, Bjerkehagen B, et al. Chondrosarcoma in Norway 1990–2013; an epidemiological and prognostic observational study of a complete national cohort. Acta Oncologica. 2019;58(3):273-282. doi: 10.1080/0284186X.2018.1554260

Damron TA, Ward WG, Stewart A. Osteosarcoma, chondrosarcoma, and Ewing’s sarcoma: National Cancer Data Base Report. Clin Orthop Relat Res. 2007;459:40-47. doi: 10.1097/BLO.0b013e318059b8c9

Pierz KA, Womer RB, Dormans JP. Pediatric bone tumors: osteosarcoma ewing’s sarcoma, and chondrosarcoma associated with multiple hereditary osteochondromatosis. J Pediatr Orthop. 2001;21(3):412-418.

Murphey MD, Choi JJ, Kransdorf MJ, Flemming DJ, Gannon FH. Imaging of osteochondroma: variants and complications with radiologic-pathologic correlation. Radiographics. 2000;20(5):1407-1434. doi: 10.1148/radiographics.20.5.g00se171407

Bernard SA, Murphey MD, Flemming DJ, Kransdorf MJ. Improved differentiation of benign osteochondromas from secondary chondrosarcomas with standardized measurement of cartilage cap at CT and MR imaging. Radiology. 2010;255(3):857-865. doi: 10.1148/radiol.10082120

Garcia RA, Inwards CY, Unni KK. Benign bone tumors-recent developments. Semin Diagn Pathol. 2011;28(1):73-85. doi: 10.1053/j.semdp.2011.02.013

Weinschenk RC, Wang WL, Lewis VO. Chondrosarcoma. J Am Acad Orthop Surg. 2021;29(13):553-562. doi: 10.5435/JAAOS-D-20-01188

Cleton-Jansen AM, van Beerendonk HM, Baelde HJ, Bovée JV, Karperien M, Hogendoorn PC. Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma. Clin Cancer Res. 2005;11(22):8028-8035. doi: 10.1158/1078-0432.CCR-05-1253

Meijer D, Gelderblom H, Karperien M, Cleton-Jansen AM, Hogendoorn PC, Bovee JV. Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo. Clin Sarcoma Res. 2011;1(1):5. doi: 10.1186/2045-3329-1-5

Lin PP, Moussallem CD, Deavers MT. Secondary chondrosarcoma. J Am Acad Orthop Surg. 2010;18(10):608-615. doi: 10.5435/00124635-201010000-00004

Wahyudi M, Astoguno Bayu Prakurso A. Gigantic secondary pelvic chondrosarcomas treated with pelvic resection type I and III: A case report. Int J Surg Case Rep. 2020;75:327-332. doi: 10.1016/j.ijscr.2020.09.082

Tsuda Y, Gregory JJ, Fujiwara T, Abudu S. Secondary chondrosarcoma arising from osteochondroma: outcomes and prognostic factors. Bone Joint J. 2019;101-B(10):1313-1320. doi: 10.1302/0301-620X.101B9.BJJ-2019-0190.R1

Righi A, Pacheco M, Cocchi S, et al. Secondary peripheral chondrosarcoma arising in solitary osteochondroma: variables influencing prognosis and survival. Orphanet J Rare Dis. 2022;17(1):74. doi: 10.1186/s13023-022-02210-2

Ahmed AR, Tan TS, Unni KK, Collins MS, Wenger DE, Sim FH. Secondary chondrosarcoma in osteochondroma: report of 107 patients. Clin Orthop Relat Res. 2003;(411):193-206. doi: 10.1097/01.blo.0000069888.31220.2b

Rozeman LB, Cleton-Jansen AM, Hogendoorn PC. Pathology of primary malignant bone and cartilage tumours. Int Orthop. 2006;30(6):437-444. doi: 10.1007/s00264-006-0212-x

Sharif B, Lindsay D, Saifuddin A. The role of imaging in differentiating low-grade and high-grade central chondral tumours. Eur J Radiol. 2021;137:109579. doi: 10.1016/j.ej-rad.2021.109579

Downloads

Published

2025-06-30

How to Cite

David, T., Narla, S. L., Subramanyan, A., & N., K. (2025). Secondary chondrosarcoma of the iliac bone in a young woman – a rare case report and review of the literature. European Journal of Clinical and Experimental Medicine, 23(2), 524–528. https://doi.org/10.15584/ejcem.2025.2.25

Issue

Vol. 23 No. 2 (2025)

Section

CASE REPORTS

License

Copyright (c) 2025 European Journal of Clinical and Experimental Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.

All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.